The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Next-Generation Drug-Eluting Stent-Global Market Insights and Sales Trends 2025
Synopsis
Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.
The global Next-Generation Drug-Eluting Stent market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Next-Generation Drug-Eluting Stent in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Next-Generation Drug-Eluting Stent market. Cobalt Chromium, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Stainless Steel segment is estimated at % CAGR for the next seven-year period.
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Next-Generation Drug-Eluting Stent, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Next-Generation Drug-Eluting Stent market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Next-Generation Drug-Eluting Stent market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Next-Generation Drug-Eluting Stent sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Next-Generation Drug-Eluting Stent covered in this report include Abbott, Biosensors International, Medtronic, Sorin Group, SMT and Terumo, etc.
The global Next-Generation Drug-Eluting Stent market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Biosensors International
Medtronic
Sorin Group
SMT
Terumo
Global Next-Generation Drug-Eluting Stent market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Next-Generation Drug-Eluting Stent market, Segment by Type:
Cobalt Chromium
Stainless Steel
Others
Global Next-Generation Drug-Eluting Stent market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Next-Generation Drug-Eluting Stent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Next-Generation Drug-Eluting Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.
The global Next-Generation Drug-Eluting Stent market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Next-Generation Drug-Eluting Stent in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Next-Generation Drug-Eluting Stent market. Cobalt Chromium, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Stainless Steel segment is estimated at % CAGR for the next seven-year period.
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Next-Generation Drug-Eluting Stent, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Next-Generation Drug-Eluting Stent market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Next-Generation Drug-Eluting Stent market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Next-Generation Drug-Eluting Stent sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Next-Generation Drug-Eluting Stent covered in this report include Abbott, Biosensors International, Medtronic, Sorin Group, SMT and Terumo, etc.
The global Next-Generation Drug-Eluting Stent market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Biosensors International
Medtronic
Sorin Group
SMT
Terumo
Global Next-Generation Drug-Eluting Stent market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Next-Generation Drug-Eluting Stent market, Segment by Type:
Cobalt Chromium
Stainless Steel
Others
Global Next-Generation Drug-Eluting Stent market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Next-Generation Drug-Eluting Stent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Next-Generation Drug-Eluting Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Next-Generation Drug-Eluting Stent Market Overview
1.1 Next-Generation Drug-Eluting Stent Product Overview
1.2 Next-Generation Drug-Eluting Stent Market Segment by Type
1.2.1 Cobalt Chromium
1.2.2 Stainless Steel
1.2.3 Others
1.3 Global Next-Generation Drug-Eluting Stent Market Size by Type
1.3.1 Global Next-Generation Drug-Eluting Stent Market Size Overview by Type (2018-2029)
1.3.2 Global Next-Generation Drug-Eluting Stent Historic Market Size Review by Type (2018-2023)
1.3.3 Global Next-Generation Drug-Eluting Stent Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Next-Generation Drug-Eluting Stent Sales Breakdown by Type (2018-2023)
1.4.2 Europe Next-Generation Drug-Eluting Stent Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Next-Generation Drug-Eluting Stent Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Next-Generation Drug-Eluting Stent Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Next-Generation Drug-Eluting Stent Sales Breakdown by Type (2018-2023)
2 Global Next-Generation Drug-Eluting Stent Market Competition by Company
2.1 Global Top Players by Next-Generation Drug-Eluting Stent Sales (2018-2023)
2.2 Global Top Players by Next-Generation Drug-Eluting Stent Revenue (2018-2023)
2.3 Global Top Players by Next-Generation Drug-Eluting Stent Price (2018-2023)
2.4 Global Top Manufacturers Next-Generation Drug-Eluting Stent Manufacturing Base Distribution, Sales Area, Product Type
2.5 Next-Generation Drug-Eluting Stent Market Competitive Situation and Trends
2.5.1 Next-Generation Drug-Eluting Stent Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Next-Generation Drug-Eluting Stent Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Next-Generation Drug-Eluting Stent as of 2022)
2.7 Date of Key Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
2.8 Key Manufacturers Next-Generation Drug-Eluting Stent Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Next-Generation Drug-Eluting Stent Status and Outlook by Region
3.1 Global Next-Generation Drug-Eluting Stent Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Next-Generation Drug-Eluting Stent Historic Market Size by Region
3.2.1 Global Next-Generation Drug-Eluting Stent Sales in Volume by Region (2018-2023)
3.2.2 Global Next-Generation Drug-Eluting Stent Sales in Value by Region (2018-2023)
3.2.3 Global Next-Generation Drug-Eluting Stent Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Next-Generation Drug-Eluting Stent Forecasted Market Size by Region
3.3.1 Global Next-Generation Drug-Eluting Stent Sales in Volume by Region (2024-2029)
3.3.2 Global Next-Generation Drug-Eluting Stent Sales in Value by Region (2024-2029)
3.3.3 Global Next-Generation Drug-Eluting Stent Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Next-Generation Drug-Eluting Stent by Application
4.1 Next-Generation Drug-Eluting Stent Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Ambulatory Surgical Centers
4.2 Global Next-Generation Drug-Eluting Stent Market Size by Application
4.2.1 Global Next-Generation Drug-Eluting Stent Market Size Overview by Application (2018-2029)
4.2.2 Global Next-Generation Drug-Eluting Stent Historic Market Size Review by Application (2018-2023)
4.2.3 Global Next-Generation Drug-Eluting Stent Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Next-Generation Drug-Eluting Stent Sales Breakdown by Application (2018-2023)
4.3.2 Europe Next-Generation Drug-Eluting Stent Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Next-Generation Drug-Eluting Stent Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Next-Generation Drug-Eluting Stent Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Next-Generation Drug-Eluting Stent Sales Breakdown by Application (2018-2023)
5 North America Next-Generation Drug-Eluting Stent by Country
5.1 North America Next-Generation Drug-Eluting Stent Historic Market Size by Country
5.1.1 North America Next-Generation Drug-Eluting Stent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Next-Generation Drug-Eluting Stent Sales in Volume by Country (2018-2023)
5.1.3 North America Next-Generation Drug-Eluting Stent Sales in Value by Country (2018-2023)
5.2 North America Next-Generation Drug-Eluting Stent Forecasted Market Size by Country
5.2.1 North America Next-Generation Drug-Eluting Stent Sales in Volume by Country (2024-2029)
5.2.2 North America Next-Generation Drug-Eluting Stent Sales in Value by Country (2024-2029)
6 Europe Next-Generation Drug-Eluting Stent by Country
6.1 Europe Next-Generation Drug-Eluting Stent Historic Market Size by Country
6.1.1 Europe Next-Generation Drug-Eluting Stent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Next-Generation Drug-Eluting Stent Sales in Volume by Country (2018-2023)
6.1.3 Europe Next-Generation Drug-Eluting Stent Sales in Value by Country (2018-2023)
6.2 Europe Next-Generation Drug-Eluting Stent Forecasted Market Size by Country
6.2.1 Europe Next-Generation Drug-Eluting Stent Sales in Volume by Country (2024-2029)
6.2.2 Europe Next-Generation Drug-Eluting Stent Sales in Value by Country (2024-2029)
7 Asia-Pacific Next-Generation Drug-Eluting Stent by Region
7.1 Asia-Pacific Next-Generation Drug-Eluting Stent Historic Market Size by Region
7.1.1 Asia-Pacific Next-Generation Drug-Eluting Stent Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Next-Generation Drug-Eluting Stent Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Next-Generation Drug-Eluting Stent Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Next-Generation Drug-Eluting Stent Forecasted Market Size by Region
7.2.1 Asia-Pacific Next-Generation Drug-Eluting Stent Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Next-Generation Drug-Eluting Stent Sales in Value by Region (2024-2029)
8 Latin America Next-Generation Drug-Eluting Stent by Country
8.1 Latin America Next-Generation Drug-Eluting Stent Historic Market Size by Country
8.1.1 Latin America Next-Generation Drug-Eluting Stent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Next-Generation Drug-Eluting Stent Sales in Volume by Country (2018-2023)
8.1.3 Latin America Next-Generation Drug-Eluting Stent Sales in Value by Country (2018-2023)
8.2 Latin America Next-Generation Drug-Eluting Stent Forecasted Market Size by Country
8.2.1 Latin America Next-Generation Drug-Eluting Stent Sales in Volume by Country (2024-2029)
8.2.2 Latin America Next-Generation Drug-Eluting Stent Sales in Value by Country (2024-2029)
9 Middle East and Africa Next-Generation Drug-Eluting Stent by Country
9.1 Middle East and Africa Next-Generation Drug-Eluting Stent Historic Market Size by Country
9.1.1 Middle East and Africa Next-Generation Drug-Eluting Stent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Next-Generation Drug-Eluting Stent Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Next-Generation Drug-Eluting Stent Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Next-Generation Drug-Eluting Stent Forecasted Market Size by Country
9.2.1 Middle East and Africa Next-Generation Drug-Eluting Stent Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Next-Generation Drug-Eluting Stent Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Next-Generation Drug-Eluting Stent Products Offered
10.1.5 Abbott Recent Development
10.2 Biosensors International
10.2.1 Biosensors International Company Information
10.2.2 Biosensors International Introduction and Business Overview
10.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Biosensors International Next-Generation Drug-Eluting Stent Products Offered
10.2.5 Biosensors International Recent Development
10.3 Medtronic
10.3.1 Medtronic Company Information
10.3.2 Medtronic Introduction and Business Overview
10.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Medtronic Next-Generation Drug-Eluting Stent Products Offered
10.3.5 Medtronic Recent Development
10.4 Sorin Group
10.4.1 Sorin Group Company Information
10.4.2 Sorin Group Introduction and Business Overview
10.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sorin Group Next-Generation Drug-Eluting Stent Products Offered
10.4.5 Sorin Group Recent Development
10.5 SMT
10.5.1 SMT Company Information
10.5.2 SMT Introduction and Business Overview
10.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2018-2023)
10.5.4 SMT Next-Generation Drug-Eluting Stent Products Offered
10.5.5 SMT Recent Development
10.6 Terumo
10.6.1 Terumo Company Information
10.6.2 Terumo Introduction and Business Overview
10.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Terumo Next-Generation Drug-Eluting Stent Products Offered
10.6.5 Terumo Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Next-Generation Drug-Eluting Stent Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Next-Generation Drug-Eluting Stent Industrial Chain Analysis
11.4 Next-Generation Drug-Eluting Stent Market Dynamics
11.4.1 Next-Generation Drug-Eluting Stent Industry Trends
11.4.2 Next-Generation Drug-Eluting Stent Market Drivers
11.4.3 Next-Generation Drug-Eluting Stent Market Challenges
11.4.4 Next-Generation Drug-Eluting Stent Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Next-Generation Drug-Eluting Stent Distributors
12.3 Next-Generation Drug-Eluting Stent Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
